Cargando…
Comparative Immunogenicity and Effectiveness of mRNA-1273, BNT162b2, and Ad26.COV2.S COVID-19 Vaccines
BACKGROUND: Understanding immunogenicity and effectiveness of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines is critical to guide rational use. METHODS: We compared the immunogenicity of mRNA-1273, BNT-162b2, and Ad26.COV2.S in healthy ambulatory adults. We performed an invers...
Autores principales: | Naranbhai, Vivek, Garcia-Beltran, Wilfredo F, Chang, Christina C, Berrios Mairena, Cristhian, Thierauf, Julia C, Kirkpatrick, Grace, Onozato, Maristela L, Cheng, Ju, St Denis, Kerri J, Lam, Evan C, Kaseke, Clarety, Tano-Menka, Rhoda, Yang, Diane, Pavlovic, Maia, Yang, Wendy, Kui, Alexander, Miller, Tyler E, Astudillo, Michael G, Cahill, Jennifer E, Dighe, Anand S, Gregory, David J, Poznansky, Mark C, Gaiha, Gaurav D, Balazs, Alejandro B, Iafrate, A John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689763/ https://www.ncbi.nlm.nih.gov/pubmed/34888672 http://dx.doi.org/10.1093/infdis/jiab593 |
Ejemplares similares
-
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts
por: Kaseke, Clarety, et al.
Publicado: (2021) -
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
por: Naranbhai, Vivek, et al.
Publicado: (2022) -
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals
por: Naranbhai, Vivek, et al.
Publicado: (2022) -
Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses
por: Nathan, Anusha, et al.
Publicado: (2021) -
Neutralization breadth of SARS-CoV-2 viral variants following primary series and booster SARS-CoV-2 vaccines in patients with cancer
por: Naranbhai, Vivek, et al.
Publicado: (2022)